{"lastClose": 5.019999980926514, "len": 1120, "date": "2023-03-24", "alpha_1": -0.38161452472561885, "beta_1": 1.5510402931771226, "drawup_1": 1.5486725887776869, "natr_1": 16.433763752634338, "sup_1": -0.02257633977706248, "res_1": 0.6281540237219838, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 23.152704788984824, "adx_1": 31.306947198976232, "drawdown_1": -0.7094907533883308, "stratHoldSharpe_1": -0.5443340679466415, "stratHoldAlpha_1": 250.63473263496354, "stratHoldDrawdown_1": -0.666908443799211, "alpha_3mo": -0.5645594328211918, "beta_3mo": 1.666742683162594, "drawup_3mo": 0.42534717220675256, "natr_3mo": 16.433763752634338, "sup_3mo": -0.009296203233190366, "res_3mo": 0.22244355360962084, "bullPattern_3mo": ["DOJI", "LONGLEGGEDDOJI", "RICKSHAWMAN", "SHORTLINE", "SPINNINGTOP"], "bearPattern_3mo": [], "rsi_3mo": 13.385832980085851, "adx_3mo": 32.36383583095504, "drawdown_3mo": -0.38855055327630106, "stratHoldSharpe_3mo": -0.642311319661465, "stratHoldAlpha_3mo": 250.6263282952994, "stratHoldDrawdown_3mo": -0.3603614951130537, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 723934973, "IPO Year": 2018.0, "Name": "Allogene Therapeutics Inc.", "Country": "United States", "alpha%_1": 0.13754303819591568, "beta%_1": 0.8810074333853475, "drawup%_1": 0.9978390295281425, "natr%_1": 0.9999990050768668, "drawdown%_1": 0.04481490923714221, "stratHoldSharpe%_1": 0.2860126108607375, "stratHoldAlpha%_1": 0.11937286320917989, "stratHoldDrawdown%_1": 0.03401015156459083, "alpha%_3mo": 0.18230808992488162, "beta%_3mo": 0.8591175992166815, "drawup%_3mo": 0.8725360635528532, "natr%_3mo": 0.9999980772616707, "drawdown%_3mo": 0.042539184145153335, "stratHoldSharpe%_3mo": 0.27619505367377606, "stratHoldAlpha%_3mo": 0.21428227003813832, "stratHoldDrawdown%_3mo": 0.03881803238508367}